A complete 2026 guide to billing Medicare Advantage plans, including prior authorization, HCC risk adjustment, star ratings, and the rising tide of MA denials.
Medicare Advantage now covers more than half of all Medicare beneficiaries, and that majority is reshaping how healthcare providers bill, document, and get paid. MA plans, while required to cover everything traditional Medicare covers, layer on prior authorization, network restrictions, payer-specific claim formats, and aggressive medical necessity reviews that traditional fee-for-service Medicare never imposed. For a billing team that treats MA claims like Medicare claims, the result is predictable: rising denials, slower payment, and revenue trapped in appeals.
This guide covers what changed, what each major plan demands, how HCC risk adjustment affects your value-based payments, and how to keep MA cash flow healthy in 2026.
Traditional Medicare (Parts A and B) is administered by CMS through Medicare Administrative Contractors (MACs). Coverage rules are uniform, prior authorization is rare, and claims process predictably under National and Local Coverage Determinations. Medicare Advantage (Part C), by contrast, is administered by private insurers who receive a capitated per-member payment from CMS and assume financial risk for each enrollee.
Because MA plans bear that risk, they manage utilization aggressively. The same service that flows through traditional Medicare without friction may require prior authorization, peer-to-peer review, and adherence to a payer-specific clinical pathway under MA. Providers must adapt to these realities at the front end of the revenue cycle.
Five insurers dominate the MA landscape. Each has distinct prior authorization patterns, claim adjudication behavior, and provider portal capabilities.
The largest MA insurer, UHC routes most MA claims through Optum and uses the UHC Provider Portal for eligibility, claim status, and PA submission. UHC's prior authorization list expanded in 2025 to cover additional outpatient procedures, and the company has been a frequent subject of OIG audits finding inappropriate denials.
Heavy presence in southern markets and HMO-style networks. Humana uses Availity for most provider transactions and emphasizes HEDIS quality reporting. Humana's "Go365" wellness program touches member experience but does not affect provider billing directly.
Operates a vertically integrated model with MinuteClinic and CVS pharmacy. Aetna's MA claim turnaround is generally fast, but pre-authorization for advanced imaging and Part B drugs is strict.
Closed network model. Most billing happens internally between Kaiser physician groups and Kaiser hospitals. External providers see Kaiser claims only when authorized referrals or emergency care occur outside the network.
Anthem, Highmark, BCBS-MI, BCBS-FL, and others operate distinct MA products under the Blue umbrella. Each follows local Blue rules; there is no single national workflow.
CMS finalized rules in 2024 (effective 2026) that meaningfully tightened MA prior authorization. Plans must now apply the same coverage criteria as traditional Medicare for services covered under Parts A and B. Approved prior authorizations remain valid for the full course of treatment. Standard PA decisions must come within 7 calendar days; expedited decisions within 72 hours. Plans must also publicly report PA metrics including approval rates and average decision times. See the CMS interoperability and prior authorization final rule for full text.
This shifts leverage modestly back toward providers, but only if billing teams document medical necessity using Medicare coverage standards (NCDs and LCDs) and escalate aged PAs aggressively. Practices that still rely on phone-based PA submission and manual tracking will not capture the benefit.
Drowning in MA prior auths?
Revenue Synergy handles end-to-end prior authorization across every major MA plan, with approval rates above 95% and turnaround under 48 hours.
Explore PA ServicesHierarchical Condition Categories (HCCs) are the diagnosis-based risk groupings that drive CMS capitation payments to MA plans. A patient with diabetes alone generates a baseline HCC weight. A patient with diabetes and CKD stage 3 generates a higher weight. Cancer, heart failure, severe COPD, amputation status, and major depression all carry meaningful HCC values.
For providers, the implication is direct. Chronic conditions must be documented and coded every calendar year, every year, even when the condition is stable. A diabetic patient seen in January 2026 with no E11 code on the claim is, for HCC purposes, a non-diabetic patient that year. The plan's risk score drops, the plan's revenue drops, and any value-based or shared-savings agreement the practice holds drops with it. Practices that participate in MA shared savings or capitation arrangements lose six-figure sums annually to undercoded chronic conditions.
CMS publishes star ratings (1 to 5 stars) for every MA plan based on roughly 40 quality and member-experience measures. Plans with 4 or more stars receive a 5% bonus on their benchmark payment. That bonus partly funds richer benefits for enrollees and partly funds quality incentive payments to network providers.
Provider contracts with high-star plans typically include HEDIS-aligned bonuses for measures like medication adherence, cancer screening, blood pressure control, and post-discharge follow-up. Practices that systematically close care gaps capture these bonuses. Practices that ignore them leave the money on the table while still bearing the documentation burden.
Medicare Advantage denial rates climbed throughout the early 2020s as plans expanded prior authorization scope and applied stricter medical necessity criteria. OIG reports found that 13% of MA prior authorization denials and 18% of payment denials were for services that would have been covered under traditional Medicare. The 2026 CMS rule directly responds to this finding by requiring MA plans to apply Medicare coverage criteria.
Effective denial management for MA requires categorizing denials by payer, denial code, and root cause; tracking appeal success rates; and escalating systemic denial patterns to plan provider relations or, when appropriate, state insurance regulators. Practices should not write off MA denials without an appeal review.
Revenue Synergy MA performance: Across 22 specialties, our clients average 24-day AR on MA claims, 95%+ first-pass acceptance, and a 73% appeal overturn rate on initial MA denials.
Strong MA billing is built on five operational pillars:
Medicare Advantage is not Medicare. It is a collection of private insurance products operating under a Medicare framework, and each plan brings its own administrative weight. Practices that treat MA as a single payer block consistently underperform on both fee-for-service revenue and value-based incentives. Practices that build payer-specific workflows, document HCCs rigorously, and appeal denials aggressively capture the full margin available in this segment.
Related: Prior Authorization Services · Denial Management · 2026 CMS Coding Updates
Need help with Medicare Advantage billing? Revenue Synergy manages MA claims for 500+ providers with $500M+ recovered. Schedule a free MA revenue audit to see where your MA workflow is leaking.